Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Patient-controlled propofol sedation for repair of obstetric perineal lacerations I–II
2022-502292-39-00Phase 3Authorised
- Sponsor
- Region Östergötland
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of propofol in perineal laceration (2 arms), sponsored by Region Östergötland. Primary endpoint: Pain/discomfort (perprocedural). Planned start Mar 2023; status: authorised.
02
Drugs
propofol
03
Conditions
perineal laceration
Beyond the preview
Go deeper on 2022-502292-39-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-502292-39-00.